Blood Cancer United Inc
The Leukemia & Lymphoma Society (now operating as Blood Cancer United) is a 501(c)(3) nonprofit organization headquartered in Washington, DC, with additional offices in Rye Brook, New York. Founded in 1949, the organization is the largest nonprofit funder of blood cancer research globally. The organization employs 1,228 staff members and operates in the United States, Canada, and nine additional countries including the United Kingdom, Argentina, Puerto Rico, and Brazil.
Key facts about Blood Cancer United Inc
- EIN
- 13-5644916
- Latest 990 filing
- Form 990-PF, 2025
- Annual giving (2025)
- $47,747,287
- Grants made (2025)
- 67
- Average grant
- $712,646
- Median grant
- $370,000
- Total assets
- $532,209,663
- Primary geography
- Massachusetts (17% of itemized 2025 grant dollars)
Data from IRS Form 990-PF, 2025; updated September 2026.
Who Blood Cancer United Inc funds
By grant dollars, the top recipient states for Blood Cancer United Inc's 67 itemized 2025 grants were Massachusetts (17%), New York (16%) and California (9%). The most frequent recipient cities were Boston, MA (5 grants), New York, NY (5 grants), Philadelphia, PA (5 grants) and Atlanta, GA (3 grants). None of its 67 grants with a stated purpose were described as general or operating support. Recurring purposes include "Research Grant" (65 grants).
Financial Overview
From 2025 IRS Form 990-PF · View filing
Total Assets
$532.2M
-11.6% YoY
Annual Giving
$47.7M
-8.6% YoY
Grant Count
67
-2.9% YoY
Avg Grant Size
$713K
-5.9% YoY
Mission & Focus Areas
Mission Statement: Cure blood cancer and improve the quality of life of all patients and their families.
The organization operates across three primary strategic areas:
Research Programs: The organization funds groundbreaking blood cancer research across the entire research continuum, from basic laboratory science through clinical trials to private-sector drug development partnerships. The organization has invested over $1.8 billion in research to date and has been instrumental in advancing 75% of nearly 100 new blood cancer treatment approvals over the past five years. Current research priorities include precision medicine, immunotherapy, and investigation of links between mutations and blood cancer. The organization has supported notable advances including Chimeric Antigen Receptor T cell (CAR T) therapy, which has produced cures for some patients who have exhausted other treatment options.
Policy & Advocacy: The organization's Policy & Advocacy team works to remove barriers to care through grassroots mobilization and advocacy to influence state and federal laws and regulations. The team focuses on ensuring all blood cancer patients have access to needed treatments and care.
Patient Support & Services: The organization provides disease information, treatment resources, support services, and educational resources for patients and families affected by blood cancer.
Grantmaking
The organization has committed significant funding to research initiatives:
Ready to take the next step with Blood Cancer United Inc?
Geographic Focus
Where this funder awards grants
The organization funds research and provides services in the United States and internationally, including Canada, the United Kingdom, Argentina, Puerto Rico, Brazil, and nine additional countries.
Grant Distribution by State
Share of all 67 itemized 2025 grant dollars.
States
Cities
Financial History
Multi-year comparison from IRS filings
Fiscal Year 2024:
- Total Revenue: $368,242,059
- Total Expenses: $371,792,172
- Total Assets: $602,010,519
- Total Liabilities: $211,000,000
Tax Status: Tax-exempt since January 2001 (EIN: 13-5644916)
Organizational Rating: The organization holds a Four-Star rating from independent charity evaluators, with a 99% overall score based on Impact & Measurement (47%), Accountability & Finance (38%), Leadership & Adaptability (10%), and Culture & Community (5%).
| Metric | 2025 | 2024 | 2023 |
|---|---|---|---|
| Total Assets | $532,209,663 | $602,010,519 | $643,891,871 |
| Revenue | $358,698,504 | $368,242,059 | $378,338,490 |
| Expenses | $398,128,476 | $371,792,172 | $386,072,968 |
| Qualifying Distributions | — | — | — |
| Net Investment Income | $22,273,771 | $16,623,882 | $15,134,480 |
| Distributable Amount | — | — | — |
Giving Over Time
Total grant dollars and number of grants per year
Grant Insights
How this funder distributes its grants
Top Recipients
Top 10 recipients in 2025
Grant Size Distribution
212 grants across all recorded years
Open Grants
6 open opportunities from Blood Cancer United Inc
Career Development Program: Fellow Award Grant
BLOOD CANCER UNITED INC
Amount
US $65,000 - US $70,000
Deadline
Rolling / Open
Career Development Program: Scholar Grant
BLOOD CANCER UNITED INC
Amount
Up to US $120,000
Deadline
Rolling / Open
Career Development Program: Scholar in Clinical Research Grant
BLOOD CANCER UNITED INC
Amount
Up to US $125,000
Deadline
Rolling / Open
Giving History
Grant recipients and amounts by year
Among its reported 2025 grants, the largest recipients include Dana-farber Cancer Institute Inc ($5,197,687), The University of Texas Md Anderson Cancer Center ($2,518,448), Sloan Kettering Institute for Cancer Research ($2,513,800).
| Recipient | Purpose | Amount |
|---|---|---|
| DANA-FARBER CANCER INSTITUTE INC BOSTON, MA | RESEARCH GRANT | $5,197,687 |
| THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER HOUSTON, TX | RESEARCH GRANT | $2,518,448 |
| SLOAN KETTERING INSTITUTE FOR CANCER RESEARCH NEW YORK, NY | RESEARCH GRANT | $2,513,800 |
| THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY STANFORD, CA | RESEARCH GRANT | $2,257,440 |
| WASHINGTON UNIVERSITY IN ST LOUIS ST LOUIS, MO | RESEARCH GRANT | $2,252,023 |
| JOAN & SANFORD I WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY NEW YORK, NY | RESEARCH GRANT | $2,115,000 |
| UNIVERSITY OF FLORIDA GAINESVILLE, FL | RESEARCH GRANT | $2,009,874 |
| UNIVERSITY OF COLORADO DENVER ANSCHUTZ MEDICAL CAMPUS AURORA, CO | RESEARCH GRANT | $1,966,500 |
| EMORY UNIVERSITY ATLANTA, GA | RESEARCH GRANT | $1,661,071 |
| FRED HUTCHINSON CANCER CENTER SEATTLE, WA | RESEARCH GRANT | $1,550,000 |
Leadership & Key People
Leadership team and compensation from IRS filings
E. Anders Kolb, M.D. - President & CEO
Louis J. DeGennaro - President and CEO (referenced in organizational materials regarding the Four-Star rating achievement)
Compensation Overview
From 2025 IRS filing
From 2025 filing
| Name | Title | Hours | Compensation |
|---|---|---|---|
| ALESSANDRA TOCCO | CHAIR | 4 | — |
| FREDA WANG | VICE CHAIR | 4 | — |
| MARLA PERSKY | SECRETARY/TREASURER | 4 | — |
| JANICE GABRILOVE MD | AT LARGE | 4 | — |
| LEROY BALL | BOD MEMBER | 4 | — |
| RICHARD BAGGER | BOD MEMBER | 4 | — |
| MARK BARRENECHEA | BOD MEMBER | 4 | — |
| RENZO CANETTA | BOD MEMBER | 4 | — |
| M CASEY CUNNINGHAM | BOD MEMBER | 4 | — |
| SHARON CASTELLINO | BOD MEMBER | 4 | — |
| MIKE FARMER | BOD MEMBER | 4 | — |
| ARI MELNICK | BOD MEMBER | 4 | — |
| KATHLEEN MERIWETHER | BOD MEMBER | 4 | — |
| RUBEN MESA | BOD MEMBER | 4 | — |
| LYNNE O'BRIEN | BOD MEMBER | 4 | — |
| ALEX OKAFOR | BOD MEMBER | 4 | — |
| JIM REDDOCH | BOD MEMBER | 4 | — |
| RICHARD RENDINA | BOD MEMBER | 4 | — |
| ROBERT ROSEN | BOD MEMBER | 4 | — |
| RAYNE H ROUCE MD | BOD MEMBER | 4 | — |
| JEFF SACHS | BOD MEMBER | 4 | — |
| LILIAN STERN | BOD MEMBER | 4 | — |
| YVETTE TREMONTI | BOD MEMBER | 4 | — |
| E ANDERS KOLB | PRESIDENT & CEO | 40 | $879,998 |
| GWEN NICHOLS | EVP, CHIEF MED OFFICER | 40 | $736,394 |
| GORDON MILLER | EVP, CHIEF FIN OFFICER | 40 | $648,480 |
| FLORA COKER POWELL | EVP, CHIEF REV OFFICER | 40 | $512,813 |
| MEREDITH FOGEL | EVP, GEN COUNSEL - START 09/2024 | 40 | $312,368 |
| SHONETTE HARRISON CAREW | EVP, CHIEF ADMIN OFF - START 09/2024 | 40 | $162,265 |
| ORLANDO ASHWORTH | EVP, CHIEF PEOPLE - START 10/2024 | 40 | $95,040 |
| LEE GREENBERGER | SVP, CHIEF SCI OFFICER - END 12/2024 | 40 | $408,560 |
| SUSAN BROWN | SVP, CHIEF SUS OFF END - 11/12/2024 | 40 | $421,797 |
| FLORENCE GODFREY | SVP, CHIEF EXPERIENCE OFFICER | 40 | $406,318 |
| ELISA WEISS | SVP, EDUCATION | 40 | $367,828 |
| ANDREW PERRY | SVP, BUS OPS AND TECHNOLOGY | 40 | $391,677 |
| DALE NISSENBAUM | FORMER EVP, GEN CNSL - END 05/2024 | 40 | $547,759 |
| TROY DUNMIRE | FORMER EVP, CF OP OFF - END 01/2024 | 40 | $263,181 |
Recent News & Activity
Recent developments and announcements
The organization has announced multiple significant research funding commitments and partnerships:
Awarded $65 million in new funding for blood cancer research
The Leukemia & Lymphoma Society Awards $65 Million in New Funding for BloodCommitted $188 million to fuel next generation of cancer research
LLS Fuels Next Generation of Cancer Research Committing $188 MillionPartnered with Blood Cancer UK to award $4.25 million for research into prevention of leukemia
The Leukemia & Lymphoma Society Awards $65 Million in New Funding for BloodInvested $6.5 million in research investigating causes of inequitable access to blood cancer treatment and care
The Leukemia & Lymphoma Society Awards $65 Million in New Funding for BloodFunded immunotherapy studies demonstrating remarkable results in patients with acute lymphoblastic leukemia
Immunotherapy Study Funded by The Leukemia & Lymphoma Society DemonstratesThe organization maintains active engagement in policy advocacy and continues to expand research initiatives focused on precision medicine, immunotherapy, and addressing health disparities in blood cancer treatment and clinical trial participation.
LLS Fuels Next Generation of Cancer Research Committing $188 MillionSubject Areas
Focus areas based on grantmaking activity
Frequently Asked Questions
What does Blood Cancer United Inc fund?
**Mission Statement:** Cure blood cancer and improve the quality of life of all patients and their families. The organization operates across three primary strategic areas: **Research Programs:** The organization funds groundbreaking blood cancer research across the entire research continuum, from basic laboratory science through clinical trials to private-sector drug development partnerships. The organization has invested over $1.8 billion in research to date and has been instrumental in advan…
How do I apply for a grant from Blood Cancer United Inc?
The organization has committed significant funding to research initiatives: • **$65 million** in new funding for blood cancer research (recent announcement) • **$188 million** commitment to fuel next generation of cancer research • **$54.6 million** in total research disbursement in fiscal year 2022, supporting research in the US, Canada, and nine other countries • **$6.5 million** invested in research investigating causes of inequitable access to blood cancer treatment and care • **$4.25 milli…
Where does Blood Cancer United Inc make grants?
The organization funds research and provides services in the United States and internationally, including Canada, the United Kingdom, Argentina, Puerto Rico, Brazil, and nine additional countries.
What size grants does Blood Cancer United Inc award?
In 2025, Blood Cancer United Inc awarded 67 grants totaling $47.7M — an average of about $713K per grant, based on its IRS Form 990 filings.
What is Blood Cancer United Inc's EIN?
Blood Cancer United Inc's EIN (Employer Identification Number) is 13-5644916. IRS Form 990 filing data is available on this page for 2019–2025.
Explore Open Grants
Browse active grant opportunities in Blood Cancer United Inc's focus areas in our free grants database
Similar Funders
Funders that support many of the same organizations
American Cancer Society Inc
ATLANTA, GA
Assets
$1.7B
Grants
348
Total Given
$86.2M
Morgan Stanley Global Impact Funding Trust Inc
INDIANAPOLIS, IN
Assets
$9.1B
Grants
19,253
Total Given
$1.2B
Mayo Clinic
ROCHESTER, MN
Assets
$26.7B
Grants
256
Total Given
$572.1M
Yale University
NEW HAVEN, CT
Assets
$55.2B
Grants
344
Total Given
$137.2M
Emory University
ATLANTA, GA
Assets
$22.2B
Grants
352
Total Given
$240.1M
Vanguard Charitable Endowment Program
SOUTHEASTERN, PA
Assets
$22.2B
Grants
24,269
Total Given
$3.0B
Vanderbilt University Medical Center
NASHVILLE, TN
Assets
$6.6B
Grants
234
Total Given
$112.3M
Bristol-myers Squibb Foundation Inc
PRINCETON, NJ
Assets
$83.3M
Grants
144
Total Given
$67.7M
National Philanthropic Trust
JENKINTOWN, PA
Assets
$42.2B
Grants
18,583
Total Given
$5.1B
Jpmorgan Chase Foundation
NEW YORK, NY
Assets
$1.2B
Grants
10,334
Total Given
$202.5M
Cystic Fibrosis Foundation
BETHESDA, MD
Assets
$5.0B
Grants
624
Total Given
$189.6M
More Funders in District of Columbia
Data last updated September 2026. Sourced from IRS Form 990-PF filings. Research dossier generated April 2026.